Research reference only. Not medical advice. Most compounds are not FDA-approved. Consult a qualified clinician before any human use.

Growth Hormone Secretion

CJC-1295

Modified GRF(1-29); Mod GRF; DAC:GRF

Classification: GHRH analog (no-DAC or DAC forms)

Mechanism: GHRH receptor agonist on pituitary somatotrophs; DAC variant binds albumin for extended half-life

Benefits: GH/IGF-1 elevation; lean mass; recovery; improved sleep; extended half-life with DAC

Evidence tier: Anecdotal + Phase 2 (DAC) · Availability: Compounding Restricted

Primary sources

  1. Teichman SL et al. Prolonged stimulation of growth hormone (GH) and IGF-I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab 2006. PMID 16352683

Loading interactive view…